Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL
Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL
Active, not recruiting · NCT04499573 · Registry updated 2023-02-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2023-02-22 | NCT04499573 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 17 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Moscow | Russia | 1 |